Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Debt to Equity: 2020-2024

Historic Debt to Equity for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $1.24.

  • Journey Medical's Debt to Equity fell 46.35% to $0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.48, marking a year-over-year increase of 92.39%. This contributed to the annual value of $1.24 for FY2024, which is 72.53% up from last year.
  • Per Journey Medical's latest filing, its Debt to Equity stood at $1.24 for FY2024, which was up 72.53% from $0.72 recorded in FY2023.
  • Journey Medical's Debt to Equity's 5-year high stood at $1.34 during FY2022, with a 5-year trough of $0.02 in FY2021.
  • Over the past 3 years, Journey Medical's median Debt to Equity value was $1.24 (recorded in 2024), while the average stood at $1.10.
  • As far as peak fluctuations go, Journey Medical's Debt to Equity plummeted by 96.19% in 2021, and later surged by 6,843.66% in 2022.
  • Over the past 5 years, Journey Medical's Debt to Equity (MRY) stood at $0.51 in 2020, then crashed by 96.19% to $0.02 in 2021, then surged by 6,843.66% to $1.34 in 2022, then tumbled by 46.42% to $0.72 in 2023, then skyrocketed by 72.53% to $1.24 in 2024.
  • Its last three reported values are $1.24 in FY2024, $0.72 for FY2023, and $1.34 during FY2022.